Full Year 2018 Onconova Therapeutics Inc Earnings Call Transcript
Good morning and welcome to the Onconova Therapeutics Corporate Update and Year-end 2018 Financial Results Conference Call. (Operator Instructions)
At this time, I'd like to turn the call over to Avi Oler, Vice President of Corporate Development and General Counsel at Onconova.
Thank you, operator. Good morning and welcome to Onconova's Corporate Update and Year-end 2018 Financial and Operating Results Conference Call. This morning, we issued a press release with full year 2018 financial results, along with business updates. The release is available on our website.
On today's call, Dr. Steve Fruchtman, our President and Chief Executive Officer, will review the company's progress and recent business and clinical highlights and milestones. Then Dr. Rick Woodman, our Chief Medical Officer, will review our clinical development programs in greater detail. After that, Mark Guerin, our Chief Financial Officer, will review the financial results. Steve will
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |